MiMedx Group, Inc. (MDXG) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+13.9%

$3.74

vs $3.28 price

Levered DCF

$4.49

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

6.57

Safe zone

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	20.52×	33.17×	18.27×	-10.3×	-64.81×	-19.74×	-31.58×	-6.39×
P/B	3.9×	7.32×	7.16×	4.21×	7.2×	10.75×	23.57×	3.81×
P/S	2.39×	4.05×	3.18×	1.17×	2.75×	3.96×	2.71×	0.53×
EV / EBITDA	10.33×	20.42×	24.38×	-28.12×	-334.61×	-25.03×	-61.8×	8.19×
Gross margin	82.6%	82.8%	83.0%	82.0%	83.6%	84.2%	85.6%	89.9%
Operating margin	15.3%	16.9%	11.5%	-5.5%	-2.9%	-18.3%	-7.1%	-1.1%
Net margin	11.6%	12.2%	21.0%	-11.3%	-5.1%	-19.9%	-8.5%	-8.3%
Current ratio	4.32×	4.21×	3.57×	3.08×	3.51×	2.71×	1.83×	1.03×
Debt / equity	0.09×	0.13×	0.34×	0.7×	0.58×	0.57×	2.03×	0×
Interest coverage	35.83×	58.51×	5.75×	-2.94×	-1.42×	-5.72×	-4.49×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	18.9%	22.0%	47.3%	-40.5%	-13.3%	-53.9%	-74.4%	-60.4%
Return on invested capital	16.7%	19.6%	19.2%	-11.4%	-4.8%	-25.2%	-20.2%	-7.6%
Return on assets	14.2%	16.1%	28.2%	-17.6%	-6.5%	-24.4%	-15.3%	-24.4%
Free cash flow yield	7.3%	4.6%	2.4%	-6.2%	-0.8%	-3.5%	-5.1%	14.0%
Earnings yield	4.9%	3.0%	6.6%	-9.6%	-1.8%	-5.0%	-3.2%	-15.9%
Enterprise value	$857M	$1.3B	$987.8M	$300.4M	$632.7M	$939M	$811.3M	$144.1M
Net debt / EBITDA	-1.73×	-1.22×	-0.84×	1.26×	17.87×	1.17×	-0.05×	-2.55×
Cash conversion cycle (days)	120	158	141	94	98	67	43	12